These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 20616724)
21. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding. Lee JM; McKean DJ; Watts TH J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939 [TBL] [Abstract][Full Text] [Related]
22. The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla. Stephen TL; Tikhonova A; Riberdy JM; Laufer TM J Immunol; 2009 Nov; 183(9):5554-62. PubMed ID: 19843939 [TBL] [Abstract][Full Text] [Related]
23. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement. Stone JD; Stern LJ J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178 [TBL] [Abstract][Full Text] [Related]
24. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells. Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095 [TBL] [Abstract][Full Text] [Related]
25. An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice. Menges PR; Jenks SA; Bikoff EK; Friedmann DR; Knowlden ZA; Sant AJ J Immunol; 2008 Feb; 180(3):1619-33. PubMed ID: 18209058 [TBL] [Abstract][Full Text] [Related]
26. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Maynard J; Petersson K; Wilson DH; Adams EJ; Blondelle SE; Boulanger MJ; Wilson DB; Garcia KC Immunity; 2005 Jan; 22(1):81-92. PubMed ID: 15664161 [TBL] [Abstract][Full Text] [Related]
27. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells. Hong J; Persaud SP; Horvath S; Allen PM; Evavold BD; Zhu C J Immunol; 2015 Oct; 195(8):3557-64. PubMed ID: 26336148 [TBL] [Abstract][Full Text] [Related]
28. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. Boehncke WH; Takeshita T; Pendleton CD; Houghten RA; Sadegh-Nasseri S; Racioppi L; Berzofsky JA; Germain RN J Immunol; 1993 Jan; 150(2):331-41. PubMed ID: 8093457 [TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749 [TBL] [Abstract][Full Text] [Related]
30. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? Tsang JY; Chai JG; Lechler R Blood; 2003 Apr; 101(7):2704-10. PubMed ID: 12433692 [TBL] [Abstract][Full Text] [Related]
31. Structure and function of major histocompatibility complex class I antigens. Li XC; Raghavan M Curr Opin Organ Transplant; 2010 Aug; 15(4):499-504. PubMed ID: 20613521 [TBL] [Abstract][Full Text] [Related]
32. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices. Smith KD; Lutz CT J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816 [TBL] [Abstract][Full Text] [Related]
33. Retroviral antibody binding of the MHC class II molecule: a biochemical influence on CD4 T cell differentiation in HIV infection? Powell PD; Demartini JC J Theor Biol; 2001 Mar; 209(2):155-60. PubMed ID: 11401457 [TBL] [Abstract][Full Text] [Related]
34. T cell receptor recognition of MHC class II alloantigens is highly cell type dependent. Katz JF; Sant AJ J Immunol; 1994 Feb; 152(4):1629-40. PubMed ID: 7907104 [TBL] [Abstract][Full Text] [Related]
35. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588 [TBL] [Abstract][Full Text] [Related]
36. On the role of high- and low-abundance class II MHC-peptide complexes in the thymic positive selection of CD4(+) T cells. Chmielowski B; Muranski P; Kisielow P; Ignatowicz L Int Immunol; 2000 Jan; 12(1):67-72. PubMed ID: 10607751 [TBL] [Abstract][Full Text] [Related]
37. The relationship between MHC restricted and allospecific T cell recognition. Lechler R; Batchelor R; Lombardi G Immunol Lett; 1991 Jul; 29(1-2):41-50. PubMed ID: 1916923 [TBL] [Abstract][Full Text] [Related]
38. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications. Afridi S; Hoessli DC; Hameed MW Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349 [TBL] [Abstract][Full Text] [Related]
39. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors. Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140 [TBL] [Abstract][Full Text] [Related]
40. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions. Cecconi V; Moro M; Del Mare S; Dellabona P; Casorati G Cytometry A; 2008 Nov; 73(11):1010-8. PubMed ID: 18612991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]